inflammation
Based on the results of the new studies, the Norwegian company is positioning its calprotectin test as an alternative to conventional ELISAs.
Beckman Coulter Gets FDA Emergency Use Authorization for COVID-19 Inflammatory Response Immunoassay
The company said that its Access Interleukin-6 assay is designed to assist physicians in the identification of severe inflammatory response in COVID-19 patients.
Roche Garners FDA Emergency Use Authorization for Elecsys IL-6 Test in COVID-19 Patients
The test measures levels of interleukin 6, which is an indicator for acute inflammation and can be used to identify COVID-19 patients at high risk of intubation.
ProciseDx Receives CE Mark for POC Gastrointestinal Disorder Assay
The CE mark advances the firm's strategy to develop and commercialize two- to five-minute tests that use fingerprick blood or stool samples, ProciseDx said.
ProciseDx, Lumiphore Ink Partnership for Rapid Point-of-Care Tests
ProciseDx anticipates bringing rapid, quantitative point-of-care tests to market in 2020 using Lumiphore's metal luminescent reporter technology.